Masitinib is targeted at patients who are no longer responding to hormone-sensitive prostate cancer treatments
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
Bayer expects 2025 to be the most difficult year of its turnaround
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
Sun Pharma has been involved in a patent infringement case with Incyte Corporation over LEQSELVI
PRX-PLUS has a unique product feature with its deep-impacting formula
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
The Formulation & Technology Centre intends to function as a technology storefront, offering advanced formulation and processing solutions to address the growing demand for complex drug formulations
Offers affordable, high-quality solutions for diabetes care
Subscribe To Our Newsletter & Stay Updated
